SCHEMBL22754851

SCHEMBL22754851

Cc1c[nH]c(=O)c2c(C(=O)Nc3ccc(N4CCOCC4)cc3)c[nH]c12

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 2/20 0.52
▸ PKM P14618 2/20 0.52
▸ NPC1 O15118 1/20 0.52
▸ TP53 P04637 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ MAPT P10636 6/20 0.51
▸ ALDH1A1 P00352 4/20 0.51
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ ROCK1 Q13464 1/20 0.51
▸ ATM Q13315 1/20 0.49
▸ NTRK1 P04629 1/20 0.48
▸ CYP1A2 P05177 1/20 0.48
▸ CYP3A4 P08684 1/20 0.48
▸ CYP2D6 P10635 1/20 0.48
▸ LMNA P02545 3/20 0.47
▸ HDAC8 Q9BY41 1/20 0.47
▸ HDAC6 Q9UBN7 1/20 0.47
▸ ITGA4 P13612 1/20 0.47
▸ L3MBTL1 Q9Y468 1/20 0.47
▸ MITF O75030 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22755207 0.79 HPGD (0.51) TP53ALDH1A1SMN1; SMN2LMNAL3MBTL1
SCHEMBL22729508 0.74 MAPT (0.54) RAB9APKMNPC1TP53MAPK1
SCHEMBL22729759 0.74 PKM (0.51) RAB9APKMNPC1TP53MAPK1
SCHEMBL13043227 0.74 MAPT (0.52) RAB9APKMNPC1TP53MAPK1
SCHEMBL22755067 0.74 MDM4 (0.46) RAB9ANPC1ALDH1A1SMN1; SMN2POLB
SCHEMBL397852 0.72 CFTR (0.66) MAPTALDH1A1ROCK1CYP1A2CYP3A4
SCHEMBL10063184 0.72 ITK (0.83) RAB9ANPC1TP53MAPTSMN1; SMN2
SCHEMBL22754962 0.71 MAPT (0.46) RAB9APKMNPC1TP53MAPK1
SCHEMBL22755341 0.71 MAPT (0.45) RAB9APKMNPC1TP53MAPK1
SCHEMBL22755172 0.71 GPR55 (0.56) RAB9APKMNPC1MAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3747885-A1 HETEROCYCLIC COMPOUND Takeda Pharmaceutical Company Limited (JP) 2020-12-09 — — EP disclosed
Send feedback